Source: Eur Respir J 2007; 30: 937-944
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
Khue P. M., Truffot-Pernot C., Texier-Maugein J., Jarlier V., Robert J., on behalf of the .... A 10-year prospective surveillance of Mycobacterium tuberculosis drug resistance in France 1995 2004. Eur Respir J 2007; 30: 937-944

Member's Comments

No comment yet.

Related content which might interest you: Mycobacterium tuberculosis drug resistance in child patients, 1989-2000 Source: Eur Respir J 2001; 18: Suppl. 33, 472s Year: 2001 First national survey results of mycobacterium tuberculosis drug resistance in Kosovo, 2007-2008 Source: Annual Congress 2011 - Epidemiology of multidrug-resistant and extensively drug-resistant tuberculosis Year: 2011 Monitoring the quality of laboratories and the prevalence of resistance to antituberculosis drugs: Italy, 1998-2000 Source: Eur Respir J 2003; 21: 129-134 Year: 2003 Molecular surveillance of multi-drug resistant tuberculosis in Europe Source: Annual Congress 2007 - Multidrug-resistant tuberculosis and the emerging threat of extensively drug-resistant tuberculosis Year: 2007 Drug resistance of mycobacterium tuberculosis isolates in Serbia over five-year period (2001-2005) Source: Annual Congress 2008 - Clinical epidemiology of tuberculosis Year: 2008 Resistance of Mycobacterium tuberculosis strains to antituberculotic drugs over the period 1999-2000 Source: Eur Respir J 2002; 20: Suppl. 38, 614s Year: 2002 Multi-drug resistant tuberculosis (MDR-TB) in Ramnicul Valcear, Romania; drug treatment, resistance testing and adverse drug reactions Source: Eur Respir J 2006; 28: Suppl. 50, 378s Year: 2006 Increasing incidence of fluoroquinolone resistant tuberculosis in Bombay Source: Annual Congress 2005 - Resistant and multidrug resistant tuberculosis Year: 2005 Extensively drug resistant tuberculosis (XDR TB) in a high income country: a report of four unrelated cases Source: Annual Congress 2007 - Multidrug-resistant tuberculosis and the emerging threat of extensively drug-resistant tuberculosis Year: 2007 Drug resistance pattern of mycobacterium tuberculosis complex at the main reference tuberculosis centre in Greece, 2000-2010 Source: Annual Congress 2011 - Epidemiology of multidrug-resistant and extensively drug-resistant tuberculosis Year: 2011 The association between HIV and antituberculosis drug resistance Source: Eur Respir J 2008; 32: 718-725 Year: 2008 Isoniazid monoresistant tuberculosis in Israel: 2000-2008 Source: Annual Congress 2010 - Emerging drug resistance in tuberculosis Year: 2010 Strategies against multidrug-resistant tuberculosis Source: Eur Respir J 2002; 20: 66S-77S Year: 2002 Recent transmission of drug resistant M. tuberculosis in Latvia Source: Annual Congress 2005 - Resistant and multidrug resistant tuberculosis Year: 2005 High rate of hepatitis due to treatment with pyrazinamide (PYR) and ethambutol (EMB) for latent tuberculosis infection (LTBI) in subjects exposed to MDR-TB Source: Annual Congress 2005 - Management of tuberculosis pulmonary, extrapulmonary peculiarities Year: 2005 Mycobacterium tuberculosis drug resistance surveillance in Belarus Source: Eur Respir J 2005; 26: Suppl. 49, 199s Year: 2005 Treatment with isoniazid or rifampin for latent tuberculosis infection: population-based study of hepatotoxicity, completion and costs Source: Eur Respir J, 55 (3) 1902048; 10.1183/13993003.02048-2019 Year: 2020 Our experience and treatment results of multidrug-resistant tuberculosis (MDR-TB) patients between 1996-2002 Source: Eur Respir J 2003; 22: Suppl. 45, 42s Year: 2003 High proportion of fluoroquinolone mono-resistant mycobacterium tuberculosis (MTB) strains in Pakistan (2010-2012) Source: Annual Congress 2013 –Drug-resistant tuberculosis Year: 2013 Treatment of TB Source: Eur Respir Mon 2012; 58: 154-166 Year: 2012